Breast Adenocarcinoma Clinical Trials

48 clinical trials for Breast Adenocarcinoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) — RECRUITING · PHASE1
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer — RECRUITING
• Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy — RECRUITING
• A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing — RECRUITING
• Preoperative Radiation Therapy and Immediate Breast Reconstruction — RECRUITING · NA
• Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study — RECRUITING · NA
• Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy — RECRUITING · PHASE1
• Definitive Radiation Therapy for Inoperable Breast Cancer — RECRUITING · NA
• Personalization of External Beam Radiation Therapy in Localised Tumours — RECRUITING
• Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer — RECRUITING · PHASE2
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study — RECRUITING
• Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic — ACTIVE_NOT_RECRUITING · PHASE3
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — ACTIVE_NOT_RECRUITING · PHASE3
• Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer — SUSPENDED · PHASE2
• Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca — ACTIVE_NOT_RECRUITING · PHASE2
• Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer — COMPLETED · PHASE2
• Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer — TERMINATED · PHASE4
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy — ACTIVE_NOT_RECRUITING
• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer — COMPLETED · PHASE2
• Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study — ACTIVE_NOT_RECRUITING
• Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer — COMPLETED · PHASE1
• Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib — COMPLETED · PHASE2
• Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer — TERMINATED
• Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer — TERMINATED · PHASE1
• The Application Value of Spectral CT in the Accurate Staging of Breast Cancer — NOT_YET_RECRUITING · NA
• Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer — COMPLETED · PHASE1
• Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas — ACTIVE_NOT_RECRUITING
• Explore Association Models Between Environmental Hormones andBreast Cancer — ACTIVE_NOT_RECRUITING
• Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer — SUSPENDED · PHASE3
• Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer — COMPLETED · PHASE1
• TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery — OTHER · PHASE2
• RBX7455 Before Surgery for the Treatment of Operable Breast Cancer — TERMINATED · PHASE1
• Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer — COMPLETED · PHASE1
• Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer — TERMINATED · NA
• Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy — WITHDRAWN · PHASE2
• Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer — COMPLETED · PHASE2
• Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer — TERMINATED · PHASE1
• Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients — OTHER · PHASE3
• PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer — TERMINATED · PHASE1
• Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer — COMPLETED · PHASE3
• Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement — COMPLETED · PHASE3
• Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas — OTHER

Refine this search